FDA offers online courses for the pharmaceutical industry

Recommendation
19/20 March 2025
Barcelona, Spain
Applying for and maintaining marketing authorisations: What you need to know from a GMP perspective
The FDA offers diverse online material as part of their CDERLearn Training and Education Program. This includes, for example:
- Case Studies
- Videos
- Webinars
However, a Continuing Education Program and general courses are also being offered. Additionally, a special section contains courses for the pharmaceutical industry. These courses offered for the industry mainly deal with questions regarding the marketing authorisation procedure in the USA. In addition, special trainings are available for sponsors of clinical studies. cGMP aspects are addressed in the courses focused on CMC topics (Chemistry, Manufacturing, Controls).
All industry courses can be found on the CDERLearn website.
Related GMP News
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications
29.01.2025EMA: Q&A Documents for "Centralized Procedures" revised
28.01.2025ANVISA recognises CEPs